Subscribe
shutterstock_1291147162_ken_wolter
Ken Wolter / Shutterstock.com
26 March 2020AmericasSarah Morgan

Abbott scores case-ending sanctions against wholesaler

Medical device maker Abbott has secured a series of case-ending sanctions against a wholesaler, bringing the five-year-long dispute to a close.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Abbott unit secures injunction against Edwards
13 March 2020   An English High Court judge has issued an injunction against Edwards Lifesciences, handing a victory to Abbott Laboratories subsidiary Evalve.
Americas
Abbott sued for patent infringement over infant probiotic
3 October 2019   Evolve BioSystems and the University of California have jointly sued Abbott Laboratories for patent infringement over a soon-to-be-launched probiotic product.
Americas
Federal Circuit remands Abbott drug test patent suit
14 April 2020   The US Court of Appeals for the Federal Circuit has ordered a new trial in a patent dispute between Abbott-subsidiary Alere and patent monetisation company Rembrandt Diagnostics.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Americas
Federal Circuit remands Abbott drug test patent suit
14 April 2020   The US Court of Appeals for the Federal Circuit has ordered a new trial in a patent dispute between Abbott-subsidiary Alere and patent monetisation company Rembrandt Diagnostics.
Europe
Abbott unit secures injunction against Edwards
13 March 2020   An English High Court judge has issued an injunction against Edwards Lifesciences, handing a victory to Abbott Laboratories subsidiary Evalve.
Americas
Abbott sued for patent infringement over infant probiotic
3 October 2019   Evolve BioSystems and the University of California have jointly sued Abbott Laboratories for patent infringement over a soon-to-be-launched probiotic product.

More on this story

Americas
Federal Circuit remands Abbott drug test patent suit
14 April 2020   The US Court of Appeals for the Federal Circuit has ordered a new trial in a patent dispute between Abbott-subsidiary Alere and patent monetisation company Rembrandt Diagnostics.
Europe
Abbott unit secures injunction against Edwards
13 March 2020   An English High Court judge has issued an injunction against Edwards Lifesciences, handing a victory to Abbott Laboratories subsidiary Evalve.
Americas
Abbott sued for patent infringement over infant probiotic
3 October 2019   Evolve BioSystems and the University of California have jointly sued Abbott Laboratories for patent infringement over a soon-to-be-launched probiotic product.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?